SAHMRI and Trajan Nutrition sign new agreement to accelerate nutrition testing worldwide

SAHMRI and Trajan Nutrition sign new agreement to accelerate nutrition testing worldwide

February 17, 2020

Adelaide, South Australia, Australia

Trajan Nutrition has signed a Memorandum of Understanding with the South Australian Health and Medical Research Institute (SAHMRI) to accelerate the translation in the global market of nutrition testing research led by professors Maria Makrides and Robert Gibson.

Trajan Scientific and Medical established Trajan Nutrition in 2017 as a joint venture with Prof Makrides and Prof Gibson, and recently appointed Mr Marco Baccanti as CEO.

Mr Baccanti, CEO of Trajan Nutrition, comments, “This new agreement will support Trajan Nutrition in offering tailored solutions and technologies for nutrition testing on a global scale; in partnership with research organisations, pathology laboratories, food and supplement companies, health insurance and corporate wellness providers.”

Under the new agreement, Trajan Nutrition and SAHMRI will leverage the know-how and the expertise of the SAHMRI Nutrition Laboratory, an analytical testing and research laboratory entirely dedicated to nutrition tests, perhaps the biggest and best-equipped in the Asia Pacific region. 

Professor Steve Wesselingh, Executive Director of SAHMRI, said, “This agreement with Trajan Nutrition is an important example of SAHMRI’s strategy to deliver translation of the results of its medical research activities into therapeutic solutions for patients, and better preventative health approaches.”

Trajan Scientific and Medical enriches the wellbeing of a growing number of communities through improved scientific and medical tools and technologies. They have completed 7 acquisitions over 6 years, increased their workforce to over 450 staff and continue to develop partnerships with unique collaboration models with academia, industry experts and likeminded organisations.

Mr. Stephen Tomisich, CEO of Trajan Scientific and Medical, said, “This marks an important milestone to accelerate our progress with Trajan Nutrition, and more broadly, with the adoption of Trajan’s microsampling technologies, a stronger focus on proactive wellness through patient-centric and delocalized healthcare.”

Mr Stephen Tomisich, CEO Trajan Scientific and Medical, Prof Steve Wesselingh, Executive Director SAHMRI, Mr Marco Baccanti, CEO Trajan Nutrition.
Photo(L-R): Mr Stephen Tomisich, CEO Trajan Scientific and Medical, Prof Steve Wesselingh, Executive Director SAHMRI, Mr Marco Baccanti, CEO Trajan Nutrition.

Download
Press release [PDF]

More information
www.trajannutrition.com
www.sahmri.org

Media contact information
Trajan Scientific and Medical
Tel: +44 (0) 1908 568 844
media@trajanscimed.com




Also in News

Trajan Scientific and Medical continues its focus on Microsampling
Trajan Scientific and Medical continues its focus on Microsampling

April 20, 2022

Trajan Scientific and Medical, (Trajan, ASX:TRJ) partnered with researchers at The University of Queensland to develop a skin microbiopsy device which takes tissue samples smaller than 0.5mm in diameter.  It can be used to collect biopsies for skin conditions, including skin cancers.

Read More

Cathy Cordova Appointed Trajan's General Manager of Microsampling Unit
Cathy Cordova Appointed Trajan's General Manager of Microsampling Unit

February 16, 2022

Cathy Cordova has been appointed the General Manager of the consolidated Microsampling Business Unit for Trajan Scientific and Medical.

Read More

Dr Xumei Gao (Bryan) awarded REDI fellowship to partner with Trajan.
Dr Xumei Gao (Bryan) awarded REDI fellowship to partner with Trajan.

January 27, 2022

 Dr Xumei Gao (Bryan) a Postdoctoral Researcher from the ARC Training Centre for Personalized Therapeutics Technologies at the University of Melbourne, has been awarded a REDI fellowship to partner with Trajan.

Read More